Sky Ridge Radiation Oncology is categorized under Family Practice Doctors in Littleton, CO and active since 2012.
Sky Ridge Radiation Oncology was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Chad Levitt at the company’s single location by writing to 10103 Ridgegate Parkway, Littleton, Colorado CO 80124 or by phoning (720) 225-4200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sky Ridge Radiation Oncology |
| Contact Person: | Chad Levitt |
| Address: | 10103 Ridgegate Parkway, Littleton, Colorado 80124 |
| Phone Number: | (720) 225-4200 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Sky Ridge Radiation Oncology was started in 2012 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Chad Levitt for inquiries that concern Sky Ridge Radiation Oncology by calling the company number (720) 225-4200, as your correspondence is most welcome. Additionally, the physical location of the single location of Sky Ridge Radiation Oncology can be found at the coordinates 39.52822,-104.872961 as well as the street address 10103 Ridgegate Parkway in Littleton, Colorado 80124.
For its online presence, you may visit Sky Ridge Radiation Oncology’s website at and engage with its social media outlets through on Twitter and on Facebook.